News BERG works with advocacy group on rare disease awareness Partnership with debra of America looks to raise awareness of lead candidate.
Views & Analysis Digital Health Round-up - Is AI the future of cancer drug de... Does artificial intelligence hold the key to cancer drug R&D?
News Ipsen charts $1.75bn course for Kartos acquisition Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
